SignatureFD
ORKA icon

SignatureFD’s Oruka Therapeutics ORKA Stock Holding History

SignatureFD’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.4K Buy
137
+44
+47% +$4.15K ﹤0.01% 2666
2026
Q2 		$8.85K Buy
93
+70
+304% +$4.66K ﹤0.01% 2683
2026
Q1 		$1.13K Buy
+23
New +$799 ﹤0.01% 3184

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

SignatureFD's ORKA Position: Q3 2026 in Review

SignatureFD increased its Oruka Therapeutics (ORKA) stake by 47% in Q3 2026, buying an estimated $4.15K and bringing the position to 137 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2666.

SignatureFD first reported a position in ORKA in Q1 2026 and has held it in 3 quarters since. 126 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

  • SignatureFD held 137 shares of Oruka Therapeutics worth $11.4K as of Q3 2026.
  • SignatureFD bought 44 Oruka Therapeutics shares in Q3 2026, an estimated $4.15K.
  • Oruka Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2666 holding.
  • SignatureFD first reported a position in Oruka Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 126 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.